Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Control-IQ+ technology

K-Number: K260429 · 2026-04-24

ApplicantTandem Diabetes Care, Inc.
Decision Date2026-04-24
Product CodeQJI
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

Control-IQ+ technology is the device name listed in this FDA 510(k) record. The listed applicant is Tandem Diabetes Care, Inc.. It received FDA 510(k) clearance on 2026-04-24 under 510(k) number K260429. The device is classified under product code QJI. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Control-IQ+ technology?

Control-IQ+ technology is a medical device that received FDA 510(k) clearance on 2026-04-24. The listed applicant is Tandem Diabetes Care, Inc.. The 510(k) number is K260429.

When did Control-IQ+ technology receive FDA 510(k) clearance?

Control-IQ+ technology received FDA 510(k) clearance on 2026-04-24, under 510(k) number K260429.

Who is the listed applicant for Control-IQ+ technology?

The FDA 510(k) record lists Tandem Diabetes Care, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Control-IQ+ technology?

The FDA product code for Control-IQ+ technology is QJI.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT05014789Control-IQ Technology 2.0 Adult and Adolescent Feasibility StudyCOMPLETEDNCT05785832A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 DiabetesCOMPLETEDNCT07325461Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 DiabetesACTIVE_NOT_RECRUITING

Other records listing Tandem Diabetes Care, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K253074Tandem Mobi insulin pump with interoperable technologyK250792t:slim X2 insulin pump with interoperable technologyK251854SteadiSet infusion setK250798Control-IQ+ technologyK243823Control-IQ+ technologyK241078Tandem Mobi Insulin Pump with interoperable technology

View all 21 devices →

Related Devices (Code: QJI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K261962SmartGuard Technology; Predictive Low Glucose TechnologyMedtronic MiniMedK261461Omnipod 6 algorithmInsulet CorporationK253701SmartGuard Technology; Predictive Low Glucose TechnologyMedtronic MinimedK253585SmartGuard technology; Predictive Low Glucose technologyMedtronic Minimed, Inc.K251152DBLG2DiabeloopK251779Omnipod 5 algorithmInsulet Corporation

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑